Huntsman Cancer Institute

What Huntsman Cancer Institute does

Huntsman Cancer Institute (HCI) is a non-profit, NCI-designated academic cancer research and treatment center operating as part of the University of Utah Health system, headquartered at 2000 Circle of Hope in Salt Lake City. Founded in 1999 and led by CEO Mary Beckerle, HCI provides comprehensive oncology services including surgery, chemotherapy, radiation therapy (notably via the Varian Edge radiosurgery system), immunotherapy, targeted therapies, clinical trials, screening and prevention, mobile outreach, and survivorship/wellness programs. Its physical footprint exceeds 1 million square feet at the flagship campus and is extended through 3 community clinics, 7 regional affiliate hospitals across the Mountain West, a mobile screening clinic, and 2 planned future locations.

HCI's core research technology centers on AI-driven discovery: a proprietary quantum mechanics-based AI method (developed by Orly Alter, PhD) that analyzes molecular features to improve cancer outcome prediction and identify drug targets, supported by the Utah Health Artificial Intelligence Vault (UHAIV) and a new AI supercomputer funded through a $33M+ State of Utah partnership stewarded jointly with the University of Utah. The Utah Population Database — one of the world's largest repositories of genetic, environmental, and health data — is being modernized with this AI infrastructure to enable predictive analytics across cancer and other disease areas.

HCI's revenue model is built on patient care services reimbursed through insurance, Medicare, and Medicaid, supplemented by federal research funding associated with its NCI designation, academic grants via the University of Utah, and philanthropic contributions channeled through the wholly-owned Huntsman Cancer Foundation subsidiary. The organization employs more than 10,000 staff across clinical, research, and administrative functions and distributes patient acquisition through physician referrals, regional affiliate partnerships, community outreach events, digital channels (website, podcast, MyChart patient portal), and direct self-serve appointment booking.

Name

Huntsman Cancer Institute

Legal name

Huntsman Cancer Institute

Website

https://huntsmancancer.org

Company type

Private

Founded year

1999

Operating status

Operating

Headcount range

10,001+ employees

Short description

Huntsman Cancer Institute is an NCI-designated, non-profit academic cancer research and treatment center within the University of Utah Health system, delivering oncology care, clinical trials, and AI-driven cancer research to patients across the Mountain West from its Salt Lake City flagship and regional affiliate network.

Ownership category

akta.pro rank

Product category

Cancer Hospital and Research Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Offices of Physicians (62111), Diagnostic Imaging Centers (621512)

SIC

Services-Hospitals (8060)

akta.pro primary industry

Oncology & Cancer Specialty Hospitals (HLAFAHAC)

akta.pro secondary industries

Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI), Medical Oncology (HLAKAFAB), Radiation Oncology (HLAKAFAC)

Keywords

• Cancer treatment services
• Clinical cancer research
• Cancer screening prevention
• Oncology clinical trials
• Cancer wellness support

Headquarters

HQ city

Salt Lake City

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales

Distribution channels5 records

Marketing channels5 records

Core offering

Huntsman Cancer Institute operates an NCI-designated academic cancer hospital and research center delivering comprehensive cancer care including surgery, chemotherapy, radiation therapy, and immunotherapy. It supports patients through screening, prevention, clinical trials, survivorship programs, and wellness services delivered across a main Salt Lake City campus, 3 community clinics, and a network of 7 regional affiliate hospitals serving the Mountain West region.

Product overview

Huntsman Cancer Institute operates as a comprehensive cancer care and research center offering a unified portfolio of integrated services. The core offerings include cancer treatment services utilizing advanced technologies such as The Varian Edge® radiosurgery system, supported by 3 community clinics, 7 regional affiliate hospitals, and 2 planned future locations across the Mountain West. Research capabilities are enhanced through clinical trials, the Utah Population Database (being modernized via the Utah Health AI Vault), and wellness services including cancer education, nutrition guidance, survivorship support, and integrative therapies. A mobile clinic extends screening services to communities across the region.

Differentiator

Problem solved

Functional benefit

Products and services

• Cancer Treatment Services Comprehensive cancer treatment services including surgery, chemotherapy, radiation therapy, and immunotherapy delivered at the Salt Lake City main facility, community clinics, and regional affiliate hospitals.
• The Varian Edge Radiosurgery System Advanced radiosurgery system enabling precise targeted radiation therapy for various cancer types, operated by Huntsman Cancer Institute clinical staff.
• Clinical Trials Clinical trials program giving cancer patients access to experimental treatments and cutting-edge research-based therapies, including research studies enrollment.
• Cancer Screening & Prevention Expert cancer screening services and prevention programs designed to detect cancer early and reduce cancer risk in patients across the Mountain West.
• Mobile Cancer Screening Clinic Mobile clinic bringing cancer screening and preventive care services to underserved communities across the Mountain West region.
• Wellness & Support Services Comprehensive supportive care including cancer education, personalized nutrition guidance, pain management, fitness programs, survivorship support, integrative therapies, and caregiver resources for cancer patients and families.

Segments3 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature3 records

Partnerships

Two partnerships are on record, tiered flagship and core.

• University of UtahflagshipStrategic or Co-development PartnerThe University of Utah, in partnership with Huntsman Cancer Institute, will steward the Utah Health AI Vault and AI supercomputer resources to modernize the Utah Population Database and accelerate AI-enabled health discoveries.
• State of Utah (7 Regional Affiliate Hospitals)coreChannel Partner/ Reseller/ DistributorNetwork of 7 regional affiliate hospitals across the Mountain West region that provide distributed access to cancer care services in collaboration with Huntsman Cancer Institute.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Mayo Clinic Comprehensive Cancer Center: NCI-designated comprehensive cancer center embedded within a large multi-specialty health system, offering the same integrated cancer care, clinical trials, and translational research as HCI with broader geographic reach.
• Memorial Sloan Kettering Cancer Center: Premier NCI-designated cancer specialty hospital and research center offering comparable inpatient/outpatient oncology care, radiation therapy, and translational research, with deeper national patient referral flows than HCI.
• MD Anderson Cancer Center: NCI-designated comprehensive cancer center and specialty hospital delivering the same oncology treatment, research, and clinical trial portfolio as HCI, but at significantly greater national/international scale and brand reach.
• Moffitt Cancer Center: NCI-designated cancer specialty hospital with a comparable focus on translational research, personalized medicine, and clinical trials, and similar scope of community/satellite clinic expansion.
• City of Hope Comprehensive Cancer Center: NCI-designated cancer specialty hospital and research center with a comparable focus on personalized treatment, clinical trials, and academic affiliation, competing for patient referrals in the western U.S.
• Stanford Cancer Institute: NCI-designated cancer center at a major academic medical institution, competing with HCI in AI-driven oncology, precision medicine, and clinical research, with deeper commercial-tech adjacency.
• Dana-Farber Cancer Institute: Harvard-affiliated NCI-designated cancer center providing directly comparable cancer treatment, clinical trials, and research, and competing with HCI for federal research funding and principal investigators.
• Roswell Park Comprehensive Cancer Center: NCI-designated comprehensive cancer center and specialty hospital offering directly comparable inpatient oncology, radiation, immunotherapy, and clinical research services.
• Fred Hutchinson Cancer Center: NCI-designated comprehensive cancer center focused on oncology treatment, immunotherapy, and population-based research, directly comparable to HCI's research-clinical integration model.
• UCSF Helen Diller Family Comprehensive Cancer Center: NCI-designated comprehensive cancer center within a major academic health system, competing with HCI for federally funded research, clinical trial enrollment, and West Coast patient referrals.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/huntsmancancer
• Facebookfacebook.com/HuntsmanCancerInstitute

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Huntsman Cancer Institute